CIK: 0001609251 · Show all filings
Period: Q4 2019 (← Previous) (Next →)
Filing Date: Feb 18, 2020
Total Value ($000): $293,048 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 460,944 | $40,600 | 13.9% | $126.32 | -30.3% | COM | 91307C102 |
| REGN | REGENERON PHARMACEUTICALS | 104,420 | $39,208 | 13.4% | $334.59 | 0.0% | COM | 75886F107 |
| MCK | MCKESSON CORP | 254,330 | $35,179 | 12.0% | $138.18 | -1.9% | COM | 58155Q103 |
| — | ALEXION PHARMACEUTICALS INC | 313,556 | $33,911 | 11.6% | $99.85 | — | COM | 015351109 |
| BIIB | BIOGEN INC | 109,904 | $32,612 | 11.1% | $314.89 | -11.9% | COM | 09062X103 |
| ENTA | ENANTA PHARMACEUTICALS INC | 489,385 | $30,234 | 10.3% | $38.94 | +59.2% | COM | 29251M106 |
| — | TARO PHARMACEUTICAL INDUS | 339,819 | $29,880 | 10.2% | $87.93 | — | COM | M8737E108 |
| ALKS | ALKERMES PLC | 905,078 | $18,464 | 6.3% | $19.88 | 0.0% | COM | G01767105 |
| — | RTI SURGICAL HDS INC | 3,628,963 | $9,943 | 3.4% | $4.39 | — | COM | 74975N105 |
| — | INVACARE CORP | 880,402 | $7,941 | 2.7% | $12.03 | — | COM | 461203101 |
| GILD | GILEAD SCIENCES INC | 121,861 | $7,919 | 2.7% | $53.09 | -3.4% | COM | 375558103 |
| ANAB | ANAPTYSBIO INC | 440,409 | $7,157 | 2.4% | $23.65 | 0.0% | COM | 032724106 |